Role of Thymus and Activation-Regulated Chemokine in Allergic Asthma
Open Access
- 1 February 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 15, 157-167
Abstract
Background: Asthma is a chronic inflammatory airway disease characterized by the predominant infiltration of inflammatory cells in the airways. Thymus and activation-regulated chemokine/C–C motif chemokine 17 (TARC/CCL17) is a chemokine responsible for trafficking T helper 2 cells into sites of allergic inflammation. Objective: To validate the role of TARC in association with clinical and inflammatory parameters in adult asthmatics. Methods: We enrolled 128 asthmatic patients and 70 healthy controls (HCs). Asthma-related clinical and laboratory parameters, including lung function and eosinophil counts, were measured. Serum levels of TARC, free immunoglobulin E (IgE), and eosinophil-derived neurotoxin (EDN) were determined by using enzyme-linked immunosorbent assay; serum total IgE level was measured using ImmunoCAP. The levels of inflammatory lipid mediators, such as leukotriene E4 (LTE4), 15-hydroxyeicosatetraenoic acid (15-HETE), thromboxane B2 (TXB2), and prostaglandin F2α (PGF2α), were measured by liquid chromatography-tandem mass spectrometry. Results: Serum TARC levels are significantly higher in asthmatics than in HCs and in allergic asthmatics than in HCs (P < 0.010 for all), with significantly negative correlations between serum TARC levels and FEV1%/MMEF% values (r = − 0.314, r = − 0.268, P < 0.050 for both). The patients with higher serum TARC levels had higher levels of serum total and free IgE levels (P < 0.050 for both) with positive correlations to serum levels of EDN, TXB2, and 15-HETE (r = 0.233, r = 0.264, and r = 0.223, respectively, P < 0.050 for all). Conclusion: We suggest the role of TARC in allergic asthma via contributing to mast cell and eosinophilic inflammation.Keywords
This publication has 40 references indexed in Scilit:
- Thymus and activation‐regulated chemokine as a clinical biomarker in atopic dermatitisThe Journal of Dermatology, 2014
- Regulation of T helper cell subsets by cyclooxygenases and their metabolitesProstaglandins & Other Lipid Mediators, 2013
- Pathogenesis of Allergic Airway InflammationCurrent Allergy and Asthma Reports, 2009
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Mast cells can promote the development of multiple features of chronic asthma in miceJournal of Clinical Investigation, 2006
- The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthmaAllergy, 2005
- ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005American Journal of Respiratory and Critical Care Medicine, 2005
- Mast-Cell Infiltration of Airway Smooth Muscle in AsthmaNew England Journal of Medicine, 2002
- Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmaticsAllergy, 2002
- Molecular and cellular mechanisms of allergic disease☆☆☆Journal of Allergy and Clinical Immunology, 2001